Data as of Jan 27
| +0.0124 / +2.01%|
The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 1.45, with a high estimate of 1.90 and a low estimate of 1.00. The median estimate represents a +130.16% increase from the last price of 0.63.
The current consensus among 2 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.